SCHEMBL4044234

SCHEMBL4044234

NS(=O)(=O)C(O)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10685279 0.75
SCHEMBL10472607 0.75 CA1 (0.43)
SCHEMBL27281111 0.72
SCHEMBL2772640 0.70
Sulfamate SCHEMBL6757265 0.69
Hydrochloric Acid SCHEMBL5155881 0.67
Sulfamate SCHEMBL22345885 0.67
Sulfuric Acid SCHEMBL10455785 0.64 BLM (0.47)
SCHEMBL73888 0.64
SCHEMBL6631948 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1641801-B9 BRIDGED N-ARYLSULFONYLPIPERIDINES AS GAMMA-SECRETASE INHIBITORS SCHERING CORP (US) 2009-02-25 EP disclosed
EP-1641801-B1 BRIDGED N-ARYLSULFONYLPIPERIDINES AS GAMMA-SECRETASE INHIBITORS SCHERING CORP (US) 2008-07-16 EP disclosed
US-7368457-B2 Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors SCHERING CORPORATION (US) 2008-05-06 US disclosed
EP-1641801-A2 BRIDGED N-ARYLSULFONYLPIPERIDINES AS GAMMA-SECRETASE INHIBITORS SCHERING CORPORATION (US) 2006-04-05 EP disclosed
WO-2004101562-A2 BRIDGED N-ARYLSULFONYLPIPERIDINES AS GAMMA-SECRETASE INHIBITORS SCHERING CORPORATION (US) 2004-11-25 WO disclosed
US-20040229902-A1 Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors SCHERING CORPORATION 2004-11-18 US disclosed